Effective use of imatinib-mesylate in the treatment of relapsed chronic myeloid leukemia after allogeneic transplantation


Autoria(s): Hayat, A.; McCann, S.R.; Langabeer, S.; Irvine, Alexandra; McMullin, Mary Frances; Conneally, E.
Data(s)

01/02/2009

Identificador

http://pure.qub.ac.uk/portal/en/publications/effective-use-of-imatinibmesylate-in-the-treatment-of-relapsed-chronic-myeloid-leukemia-after-allogeneic-transplantation(f4a7eabf-255a-4061-9bef-88732b38b4a9).html

http://dx.doi.org/10.3324/haematol.13353

http://www.scopus.com/inward/record.url?scp=59449099547&partnerID=8YFLogxK

Idioma(s)

eng

Direitos

info:eu-repo/semantics/restrictedAccess

Fonte

Hayat , A , McCann , S R , Langabeer , S , Irvine , A , McMullin , M F & Conneally , E 2009 , ' Effective use of imatinib-mesylate in the treatment of relapsed chronic myeloid leukemia after allogeneic transplantation ' Haematologica , vol 94 , no. 2 , pp. 296-298 . DOI: 10.3324/haematol.13353

Palavras-Chave #/dk/atira/pure/subjectarea/asjc/2700/2720 #Hematology
Tipo

article